These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34320495)

  • 1. CYP24A1 and SLC34A1 Pathogenic Variants Are Uncommon in a Canadian Cohort of Children with Hypercalcemia or Hypercalciuria.
    Rousseau-Nepton I; Jones G; Schlingmann K; Kaufmann M; Zuijdwijk CS; Khatchadourian K; Gupta IR; Pacaud D; Pinsk MN; Mokashi A; Nour MA; Alexander RT; Rodd CJ
    Horm Res Paediatr; 2021; 94(3-4):124-132. PubMed ID: 34320495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of vitamin D
    Kowalska E; Rola R; Wójcik M; Łaszcz N; Płudowski P; Wierzbicka A; Janiec A; Książyk J; Halat P; Ciara E; Obrycki Ł; Pronicka E; Litwin M
    J Steroid Biochem Mol Biol; 2021 Apr; 208():105824. PubMed ID: 33516786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biallelic and monoallelic pathogenic variants in CYP24A1 and SLC34A1 genes cause idiopathic infantile hypercalcemia.
    Wang Q; Chen JJ; Wei LY; Ding Y; Liu M; Li WJ; Su C; Gong CX
    Orphanet J Rare Dis; 2024 Mar; 19(1):126. PubMed ID: 38504242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biallelic mutations in CYP24A1 or SLC34A1 as a cause of infantile idiopathic hypercalcemia (IIH) with vitamin D hypersensitivity: molecular study of 11 historical IIH cases.
    Pronicka E; Ciara E; Halat P; Janiec A; Wójcik M; Rowińska E; Rokicki D; Płudowski P; Wojciechowska E; Wierzbicka A; Książyk JB; Jacoszek A; Konrad M; Schlingmann KP; Litwin M
    J Appl Genet; 2017 Aug; 58(3):349-353. PubMed ID: 28470390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic infantile hypercalcemia: mutations in SLC34A1 and CYP24A1 in two siblings and fathers.
    Güven A; Konrad M; Schlingmann KP
    J Pediatr Endocrinol Metab; 2020 Aug; 33(10):1353-1358. PubMed ID: 32866123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mild Idiopathic Infantile Hypercalcemia-Part 1: Biochemical and Genetic Findings.
    Lenherr-Taube N; Young EJ; Furman M; Elia Y; Assor E; Chitayat D; Uster T; Kirwin S; Robbins K; Vinette KMB; Daneman A; Marshall CR; Collins C; Thummel K; Sochett E; Levine MA
    J Clin Endocrinol Metab; 2021 Sep; 106(10):2915-2937. PubMed ID: 34125233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overlapping Phenotypes Associated With
    Molin A; Lemoine S; Kaufmann M; Breton P; Nowoczyn M; Ballandonne C; Coudray N; Mittre H; Richard N; Ryckwaert A; Lavillaureix A; Jones G; Bacchetta J; Kottler ML
    Front Endocrinol (Lausanne); 2021; 12():736240. PubMed ID: 34721296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome of the survivors of infantile hypercalcaemia with CYP24A1 and SLC34A1 mutations.
    Janiec A; Halat-Wolska P; Obrycki Ł; Ciara E; Wójcik M; Płudowski P; Wierzbicka A; Kowalska E; Książyk JB; Kułaga Z; Pronicka E; Litwin M
    Nephrol Dial Transplant; 2021 Jul; 36(8):1484-1492. PubMed ID: 33099630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autosomal-Recessive Mutations in SLC34A1 Encoding Sodium-Phosphate Cotransporter 2A Cause Idiopathic Infantile Hypercalcemia.
    Schlingmann KP; Ruminska J; Kaufmann M; Dursun I; Patti M; Kranz B; Pronicka E; Ciara E; Akcay T; Bulus D; Cornelissen EA; Gawlik A; Sikora P; Patzer L; Galiano M; Boyadzhiev V; Dumic M; Vivante A; Kleta R; Dekel B; Levtchenko E; Bindels RJ; Rust S; Forster IC; Hernando N; Jones G; Wagner CA; Konrad M
    J Am Soc Nephrol; 2016 Feb; 27(2):604-14. PubMed ID: 26047794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP24A1 Mutations in a Cohort of Hypercalcemic Patients: Evidence for a Recessive Trait.
    Molin A; Baudoin R; Kaufmann M; Souberbielle JC; Ryckewaert A; Vantyghem MC; Eckart P; Bacchetta J; Deschenes G; Kesler-Roussey G; Coudray N; Richard N; Wraich M; Bonafiglia Q; Tiulpakov A; Jones G; Kottler ML
    J Clin Endocrinol Metab; 2015 Oct; 100(10):E1343-52. PubMed ID: 26214117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney function and influence of sunlight exposure in patients with impaired 24-hydroxylation of vitamin D due to CYP24A1 mutations.
    Figueres ML; Linglart A; Bienaime F; Allain-Launay E; Roussey-Kessler G; Ryckewaert A; Kottler ML; Hourmant M
    Am J Kidney Dis; 2015 Jan; 65(1):122-6. PubMed ID: 25446019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP24A1 loss of function: Clinical phenotype of monoallelic and biallelic mutations.
    Carpenter TO
    J Steroid Biochem Mol Biol; 2017 Oct; 173():337-340. PubMed ID: 28093352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do the Heterozygous Carriers of a CYP24A1 Mutation Display a Different Biochemical Phenotype Than Wild Types?
    Brancatella A; Cappellani D; Kaufmann M; Borsari S; Piaggi P; Baldinotti F; Caligo MA; Jones G; Marcocci C; Cetani F
    J Clin Endocrinol Metab; 2021 Mar; 106(3):708-717. PubMed ID: 33249478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP24A1 and SLC34A1 genetic defects associated with idiopathic infantile hypercalcemia: from genotype to phenotype.
    De Paolis E; Scaglione GL; De Bonis M; Minucci A; Capoluongo E
    Clin Chem Lab Med; 2019 Oct; 57(11):1650-1667. PubMed ID: 31188746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3' Untranslated Region Structural Elements in CYP24A1 Are Associated With Infantile Hypercalcemia Type 1.
    Ball N; Duncan S; Zhang Y; Payet R; Piec I; Whittle E; Tang JCY; Schoenmakers I; Lopez B; Chipchase A; Kumar A; Perry L; Maxwell H; Ding Y; Fraser WD; Green D
    J Bone Miner Res; 2023 Mar; 38(3):414-426. PubMed ID: 36625425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic infantile hypercalcemia in children with chronic kidney disease due to kidney hypodysplasia.
    Gurevich E; Borovitz Y; Levi S; Perlman S; Landau D
    Pediatr Nephrol; 2023 Apr; 38(4):1067-1073. PubMed ID: 36156733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium and bone homeostasis in heterozygous carriers of CYP24A1 mutations: A cross-sectional study.
    Cools M; Goemaere S; Baetens D; Raes A; Desloovere A; Kaufman JM; De Schepper J; Jans I; Vanderschueren D; Billen J; De Baere E; Fiers T; Bouillon R
    Bone; 2015 Dec; 81():89-96. PubMed ID: 26117226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss-of-function mutations of CYP24A1, the vitamin D 24-hydroxylase gene, cause long-standing hypercalciuric nephrolithiasis and nephrocalcinosis.
    Dinour D; Beckerman P; Ganon L; Tordjman K; Eisenstein Z; Holtzman EJ
    J Urol; 2013 Aug; 190(2):552-7. PubMed ID: 23470222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved Screening Test for Idiopathic Infantile Hypercalcemia Confirms Residual Levels of Serum 24,25-(OH)
    Kaufmann M; Morse N; Molloy BJ; Cooper DP; Schlingmann KP; Molin A; Kottler ML; Gallagher JC; Armas L; Jones G
    J Bone Miner Res; 2017 Jul; 32(7):1589-1596. PubMed ID: 28304097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AN INFANT WITH IDIOPATHIC HYPERCALCIURIA AND NEPHROLITHIASIS ASSOCIATED WITH CYP24A1 ENZYME POLYMORPHISM: A CASE REPORT.
    Trutin I; Škorić I
    Acta Clin Croat; 2022 Feb; 60(3):544-547. PubMed ID: 35282483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.